A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 31/4745 (2006.01) A61K 31/513 (2006.01) A61K 31/517 (2006.01) A61K 31/704 (2006.01) A61K 31/7088 (2006.01) A61K 33/24 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2511604
The present invention provides a method of killing cancer cells and method of treatment of cancer comprising administration of a therapeutically effective amount of a) a specific binding member which binds to a cell death receptor or a nucleic acid encoding said binding member and (b) a chemotherapeutic agent. The binding member pereferably binds to a Fas receptor. Also described are medicaments for use in treating cancer.
La présente invention concerne une méthode de neutralisation de cellules cancéreuses et une méthode de traitement du cancer, qui consistent à administrer une quantité thérapeutiquement efficace: a) d'un élément de liaison spécifique qui se lie à un récepteur de la mort cellulaire ou un acide nucléique codant ledit élément; et b) d'une substance chimiothérapeutique. L'élément de liaison se lie, de préférence, à un récepteur de Fas. L'invention concerne en outre des médicaments destinés au traitement du cancer.
Johnston Patrick
Longley Daniel
Fusion Antibodies Limited
Gowling Lafleur Henderson Llp
LandOfFree
Treatment of cancer by the use of anti fas antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cancer by the use of anti fas antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer by the use of anti fas antibody will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1592833